51
Views
0
CrossRef citations to date
0
Altmetric
Letter to the Editor

Successful haploidentical bone marrow transplantation in Griscelli syndrome type 2 with non-busulfan-based regimen and post-transplantation cyclophosphamide: a case report and review of the literature

, , ORCID Icon, , , , ORCID Icon, , , , , & ORCID Icon show all
Pages 296-300 | Received 02 Jun 2023, Accepted 17 Oct 2023, Published online: 31 Oct 2023

References

  • Pachlopnik Schmid J, Moshous D, Boddaert N, et al. Hematopoietic stem cell transplantation in Griscelli syndrome type 2: a single-center report on 10 patients. Blood. Jul 2 2009;114(1):211–218. doi:10.1182/blood-2009-02-207845.
  • Al-Mofareh M, Ayas M, Al-Seraihy A, et al. Hematopoietic stem cell transplantation in children with Griscelli syndrome type 2: a single-center report on 35 patients. Bone Marrow Transplant. Oct 2020;55(10):2026–2034. doi:10.1038/s41409-020-0885-6.
  • Zhang Q, Zhao YZ, Ma HH, et al. Successful rescue of a lethal Griscelli syndrome type 2 presenting with neurological involvement and hemophagocytic lymphohistiocytosis: a case report. BMC Pediatr. May 31 2021;21(1):253. doi:10.1186/s12887-021-02720-1.
  • Nishi M, Nishimura R, Suzuki N, et al. Reduced-intensity conditioning in unrelated donor cord blood transplantation for familial hemophagocytic lymphohistiocytosis. Am J Hematol. Jun 2012;87(6):637–639. doi:10.1002/ajh.23190.
  • Marsh RA, Hebert K, Kim S, et al. Comparison of hematopoietic cell transplant conditioning regimens for hemophagocytic lymphohistiocytosis disorders. J Allergy Clin Immunol. Mar 2022;149(3):1097–1104.e2. doi:10.1016/j.jaci.2021.07.031.
  • Hamidieh AA, Pourpak Z, Yari K, et al. Hematopoietic stem cell transplantation with a reduced-intensity conditioning regimen in pediatric patients with Griscelli syndrome type 2. Pediatr Transplant. Aug 2013;17(5):487–491. doi:10.1111/petr.12092.
  • Patiroglu T, Akar HH, Unal E, Ozdemir MA, Karakukcu M. Hematopoietic Stem Cell Transplant for Primary Immunodeficiency Diseases: A Single-Center Experience. Exp Clin Transplant. Jun 2017;15(3):337–343. doi:10.6002/ect.2015.0233.
  • Uppuluri R, Sivasankaran M, Patel S, et al. Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide for Primary Immune Deficiency Disorders in Children: Challenges and Outcome from a Tertiary Care Center in South India. J Clin Immunol. Feb 2019;39(2):182–187. doi:10.1007/s10875-019-00600-z.
  • Swaminathan VV, Uppuluri R, Meena SK, et al. Treosulfan-Based Conditioning in Matched Family, Unrelated and Haploidentical Hematopoietic Stem Cell Transplantation for Genetic Hemophagocytic Lymphohistiocytosis: Experience and Outcomes over 10 Years from India. Indian J Hematol Blood Transfus. Jan 2022;38(1):84–91. doi:10.1007/s12288-021-01422-z.
  • Felber M, Steward CG, Kentouche K, et al. Targeted busulfan-based reduced-intensity conditioning and HLA-matched HSCT cure hemophagocytic lymphohistiocytosis. Blood Adv. 2020;4(9):1998–2010. Blood Adv. Aug 25 2020;4(16):3926. doi:10.1182/bloodadvances.2020003085.
  • Vrooman LM, Millard HR, Brazauskas R, et al. Survival and Late Effects after Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancy at Less than Three Years of Age. Biol Blood Marrow Transplant. Aug 2017;23(8):1327–1334. doi:10.1016/j.bbmt.2017.04.017.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.